Oasis asks questions about CFR’s offer for Adcock Ingram

Oasis is lone voice of dissent in Brazilian pharmaceutical group’s cash-and-shares deal, saying it would have backed all-cash deal but does not want to own CFR stock

Powered by WPeMatico

This entry was posted in Business. Bookmark the permalink.

Comments are closed.